Playback speed
10 seconds
ASH 2023 Insights: "Fixed-Duration Pirtobrutinib Combined With Venetoclax ± Rituximab in R/R CLL - Updated BRUIN Study Results Including MRD Data"
By
Insights from 2023 ASH Annual Meeting
FEATURING
Nirav Shah
By
Insights from 2023 ASH Annual Meeting
FEATURING
Nirav Shah
351 views
December 18, 2023
Login to view comments.
Click here to Login